Juergen Reess

702 total citations
10 papers, 534 citations indexed

About

Juergen Reess is a scholar working on Neurology, Epidemiology and Cognitive Neuroscience. According to data from OpenAlex, Juergen Reess has authored 10 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 8 papers in Epidemiology and 5 papers in Cognitive Neuroscience. Recurrent topics in Juergen Reess's work include Parkinson's Disease Mechanisms and Treatments (8 papers), Restless Legs Syndrome Research (8 papers) and Sleep and Wakefulness Research (5 papers). Juergen Reess is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (8 papers), Restless Legs Syndrome Research (8 papers) and Sleep and Wakefulness Research (5 papers). Juergen Reess collaborates with scholars based in Germany, Finland and United States. Juergen Reess's co-authors include Juergen Koester, Ilkka Tamminen, Kari Hirvonen, Anniina Alakuijala, Wolfgang H. Oertel, Markku Partinen, Christer Hublin, Karin Stiasny‐Kolster, Philip M. Becker and Kapil D. Sethi and has published in prestigious journals such as Neurology, Movement Disorders and Sleep Medicine.

In The Last Decade

Juergen Reess

10 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Juergen Reess Germany 8 485 443 372 51 36 10 534
C EARLEY United States 6 370 0.8× 285 0.6× 271 0.7× 79 1.5× 48 1.3× 8 413
Ines Peglau Germany 8 345 0.7× 289 0.7× 243 0.7× 75 1.5× 32 0.9× 11 403
Hanna Scholz Germany 8 228 0.5× 181 0.4× 168 0.5× 34 0.7× 15 0.4× 10 281
J. Kazenwadel Germany 6 389 0.8× 333 0.8× 346 0.9× 83 1.6× 21 0.6× 8 480
Paul R. Stillman United Kingdom 5 271 0.6× 197 0.4× 189 0.5× 62 1.2× 11 0.3× 8 326
Yolanda de la Llave Spain 6 353 0.7× 302 0.7× 371 1.0× 130 2.5× 12 0.3× 7 484
J. J. M. Askenasy Israel 9 132 0.3× 181 0.4× 150 0.4× 80 1.6× 8 0.2× 18 312
Anik Gosselin Canada 6 236 0.5× 176 0.4× 381 1.0× 190 3.7× 14 0.4× 6 450
Renata Egatz Germany 3 281 0.6× 257 0.6× 204 0.5× 41 0.8× 23 0.6× 4 297
Evi Holzknecht Austria 10 128 0.3× 132 0.3× 140 0.4× 62 1.2× 18 0.5× 26 249

Countries citing papers authored by Juergen Reess

Since Specialization
Citations

This map shows the geographic impact of Juergen Reess's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juergen Reess with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juergen Reess more than expected).

Fields of papers citing papers by Juergen Reess

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juergen Reess. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juergen Reess. The network helps show where Juergen Reess may publish in the future.

Co-authorship network of co-authors of Juergen Reess

This figure shows the co-authorship network connecting the top 25 collaborators of Juergen Reess. A scholar is included among the top collaborators of Juergen Reess based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juergen Reess. Juergen Reess is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Ondo, William G., Md Monir Hossain, Mark Forrest Gordon, & Juergen Reess. (2013). Predictors of placebo response in restless legs syndrome studies. Neurology. 81(2). 193–194. 16 indexed citations
2.
Hirvonen, Kari, Markku Partinen, Anniina Alakuijala, et al.. (2009). A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: Polysomnographic evaluation of periodic leg movements and sleep disturbance. Sleep Medicine. 10(6). 630–636. 34 indexed citations
3.
Partinen, Markku, Kari Hirvonen, Anniina Alakuijala, et al.. (2008). Open-label study of the long-term efficacy and safety of pramipexole in patients with Restless Legs Syndrome (extension of the PRELUDE study). Sleep Medicine. 9(5). 537–541. 31 indexed citations
4.
Partinen, Markku, Kari Hirvonen, Anniina Alakuijala, et al.. (2006). Efficacy and safety of pramipexole in idiopathic restless legs syndrome: A polysomnographic dose-finding study—The PRELUDE study. Sleep Medicine. 7(5). 407–417. 110 indexed citations
5.
Oertel, Wolfgang H., Karin Stiasny‐Kolster, Yngve Hallström, et al.. (2006). Efficacy of pramipexole in restless legs syndrome: A six‐week, multicenter, randomized, double‐blind study (effect‐RLS study). Movement Disorders. 22(2). 213–219. 94 indexed citations
6.
Trenkwalder, Claudia, Karin Stiasny‐Kolster, Andreas Kupsch, et al.. (2006). Controlled withdrawal of pramipexole after 6 months of open‐label treatment in patients with restless legs syndrome. Movement Disorders. 21(9). 1404–1410. 67 indexed citations
7.
Winkelman, John W., Kapil D. Sethi, Clete A. Kushida, et al.. (2006). Efficacy and safety of pramipexole in restless legs syndrome. Neurology. 67(6). 1034–1039. 143 indexed citations
8.
Wunderlich, Glen, Kenneth Evans, Terrence Sills, et al.. (2005). An item response analysis of the international restless legs syndrome study group rating scale for restless legs syndrome. Sleep Medicine. 6(2). 131–139. 33 indexed citations
9.
Reess, Juergen, E. Mauch, & Kornhuber Hh. (1992). [Simultaneous occurrence of sarcoidosis and MS or sarcoidosis within the clinical picture of multiple sclerosis?].. PubMed. 63(8). 503–5. 2 indexed citations
10.
Reess, Juergen, E. Mauch, & H. H. Kornhuber. (1991). [Subacute organic psychosyndrome as a clinical manifestation of infection with stage II Borrelia burgdorferi without further neurologic manifestations].. PubMed. 62(8). 514–5. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C EARLEY Breakdown of academic impact, for papers by Ines Peglau Breakdown of academic impact, for papers by Hanna Scholz Breakdown of academic impact, for papers by J. Kazenwadel Breakdown of academic impact, for papers by Paul R. Stillman Breakdown of academic impact, for papers by Yolanda de la Llave Breakdown of academic impact, for papers by J. J. M. Askenasy Breakdown of academic impact, for papers by Anik Gosselin Breakdown of academic impact, for papers by Renata Egatz Breakdown of academic impact, for papers by Evi Holzknecht
Rankless by CCL
2026